Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isatuximab and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma Patients (Isabel Study)

NCT04965155 is registered in ClinicalTrials.gov with EMN Trial Office S.r.l. Impresa Sociale as lead sponsor.

NCT NCT04965155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04965155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isatuximab and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma Patients (Isabel Study)
Lead sponsor
EMN Trial Office S.r.l. Impresa Sociale
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 21, 2021
Completion date
March 31, 2027
Enrollment
50 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed multiple myeloma